EU delays approval of Novavax’s revised Covid jab
Liberate the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favorite tales on this weekly e-newsletter.EU regulators have behind schedule a choice to approve Novavax’s variant-tailored Covid-19 vaccine, in